Withdrawal reaction after sertraline discontinuation.
Louie
A K
AK
Lannon
R A
RA
Ajari
L J
LJ
D015057:1-Naphthylamine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D001008:Anxiety Disorders / Q000188:drug therapy; D005260:Female; D006207:Half-Life; D006801:Humans; D008875:Middle Aged; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics; D020280:Sertraline; D013375:Substance Withdrawal Syndrome / Q000209:etiology*
D015057:1-Naphthylamine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline